Pilot project INTEGRATE: Development of integrated strategies to monitor and treat chronic and rheumatic diseases

Call: Pilot project INTEGRATE: Development of integrated strategies to monitor and treat chronic and rheumatic diseases

Logo

Programme

Health Programme

Type of Fund

Action programme

Description of programme
"Health Programme "

The EU is required by its founding treaty to ensure that human health is protected as part of all its policies, and to work with the EU countries to improve public health, prevent human illness and eliminate sources of danger to physical and mental health.

The 3rd Health Programme has 4 overarching objectives. It seeks to:

Promote health, prevent diseases and foster supportive environments for healthy lifestyles taking into account the 'health in all policies' principle,
Protect Union citizens from serious cross-border health threats,
Contribute to innovative, efficient and sustainable health systems,
Facilitate access to better and safer healthcare for Union citizens.

The third EU health programme is the main instrument the European Commission uses to implement the EU health strategy. It is implemented by means of annual work plans which set out priority areas and the criteria for funding actions under the programme. The total budget for the programme is € 449.4 million.

Link

http://ec.europa.eu/health/programme/policy/index_en.htm

Call

Pilot project INTEGRATE: Development of integrated strategies to monitor and treat chronic and rheumatic diseases

Description of call
" Pilot project INTEGRATE: Development of integrated strategies to monitor and treat chronic and rheumatic diseases"

Objective: Development of integrated strategies to monitor and treat chronic and rheumatic diseases - the role of quality indicators and patient reported outcomes in addition to the physician evaluation of disease activity and damage

It is generally acknowledged that the clinical picture observed in many chronic diseases (such as diabetes, cardiovascular diseases, neurological disorders and rheumatic diseases) is the result of the combination of different components: disease activity, damage consequent to the disease itself or the treatment, comorbidities, drug toxicity, quality of life and disease burden on patients. Therefore, optimal treatment and management of chronic diseases means that these aspects have to be factored in.

In particular, musculo-skeletal diseases such as rheumatic diseases are often associated with other chronic conditions, such as diabetes, other autoimmune diseases, and cardiovascular, or mental diseases, such as depression. However, chronic musculoskeletal conditions are not always considered priorities in chronic disease prevention.

This pilot project should thus focus on exploring the potential of specific quality indicators, and patient-reported outcomes in addition to the more traditional reports of physicians towards developing an effective strategy to prevent and treat musculoskeletal diseases such as rheumatic diseases, focusing on rheumatic connective tissue diseases, taking multimorbidity as well as integrated care for such patients into account.

Link

https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/3hp/topics/pp-2-4-2016.html

Thematic Focus

Health, Research

Funding area

EU Member States

Select Origin of Applicant

EU Member States
Iceland / Ísland
Norway / Norge

Eligible applicants

Public Services, University, Research Institution

Project Partner

Yes

Project Partner Details

Proposals must be submitted by consortia of legal entities (with or without legal personality) established in at least 2 different EU Member States.

Project duration max

24 months

Type of Funding

Grant

Financial details

The total budget earmarked for the co-financing of projects is estimated at 500 000 €. The maximum possible rate of co-financing of the eligible total costs is 60%.

News